TY - JOUR
T1 - FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model
AU - Xiao, Zhousheng
AU - King, Gwendalyn
AU - Mancarella, Salvatore
AU - Munkhsaikhan, Undral
AU - Cao, Li
AU - Cai, Chun
AU - Quarles, Leigh Darryl
N1 - Funding Information:
This work was supported by grant R01-AR045955 to LDQ from the NIH. We thank Tami Rubinek and Ido Wolf for providing the Klotho constructs in this study.
Funding Information:
Study approval. All animal research was conducted according to guidelines provided by the National Institutes of Health (NIH) and the Institute of Laboratory Animal Resources, National Research Council. The University of Tennessee Health Science Center’s Animal Care and Use Committee approved all animal studies (protocol 18-111.0).
Publisher Copyright:
© 2019, American Society for Clinical Investigation.
PY - 2019/12/5
Y1 - 2019/12/5
N2 - Observations in transgenic α-Klotho (Kl) mice (KlTg) defined the antiaging role of soluble Klotho (sKL130). A genetic translocation that elevates sKL levels in humans is paradoxically associated with increased circulating fibroblast growth factor 23 (FGF23) levels and the potential of both membrane KL (mKL135) and sKL130 to act as coreceptors for FGF23 activation of fibroblast growth factor receptors (FGFRs). Neither FGF23 expression nor the contributions of FGF23, mKL135, and sKL130 codependent and independent functions have been investigated in KlTg mice. In the current study, we examined the effects of Kl overexpression on FGF23 levels and functions in KlTg mice. We found that mKL135 but not sKL130 stimulated FGF23 expression in osteoblasts, leading to elevated Fgf23 bone expression and circulating levels in KlTg mice. Elevated FGF23 suppressed 1,25(OH)2D and parathyroid hormone levels but did not cause hypophosphatemic rickets in KlTg mice. KlTg mice developed low aldosterone-associated hypertension but not left ventricular hypertrophy. Mechanistically, we found that mKL135 and sKL130 are essential cofactors for FGF23-mediated ERK activation but that they inhibited FGF23 stimulation of PLC-γ and PI3K/AKT signaling. Thus, increased longevity in KlTg mice occurs in the presence of excess FGF23 that interacts with mKL and sKL to bias FGFR pathways.
AB - Observations in transgenic α-Klotho (Kl) mice (KlTg) defined the antiaging role of soluble Klotho (sKL130). A genetic translocation that elevates sKL levels in humans is paradoxically associated with increased circulating fibroblast growth factor 23 (FGF23) levels and the potential of both membrane KL (mKL135) and sKL130 to act as coreceptors for FGF23 activation of fibroblast growth factor receptors (FGFRs). Neither FGF23 expression nor the contributions of FGF23, mKL135, and sKL130 codependent and independent functions have been investigated in KlTg mice. In the current study, we examined the effects of Kl overexpression on FGF23 levels and functions in KlTg mice. We found that mKL135 but not sKL130 stimulated FGF23 expression in osteoblasts, leading to elevated Fgf23 bone expression and circulating levels in KlTg mice. Elevated FGF23 suppressed 1,25(OH)2D and parathyroid hormone levels but did not cause hypophosphatemic rickets in KlTg mice. KlTg mice developed low aldosterone-associated hypertension but not left ventricular hypertrophy. Mechanistically, we found that mKL135 and sKL130 are essential cofactors for FGF23-mediated ERK activation but that they inhibited FGF23 stimulation of PLC-γ and PI3K/AKT signaling. Thus, increased longevity in KlTg mice occurs in the presence of excess FGF23 that interacts with mKL and sKL to bias FGFR pathways.
UR - http://www.scopus.com/inward/record.url?scp=85077759754&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077759754&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.132820
DO - 10.1172/jci.insight.132820
M3 - Article
C2 - 31801907
AN - SCOPUS:85077759754
VL - 4
JO - JCI insight
JF - JCI insight
SN - 2379-3708
IS - 23
M1 - e132820
ER -